Adva Kubi

1.5k total citations
13 papers, 1.2k citations indexed

About

Adva Kubi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Adva Kubi has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Adva Kubi's work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (5 papers) and Cell Adhesion Molecules Research (3 papers). Adva Kubi is often cited by papers focused on CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (5 papers) and Cell Adhesion Molecules Research (3 papers). Adva Kubi collaborates with scholars based in Israel, United States and Australia. Adva Kubi's co-authors include Michal J. Besser, Orit Itzhaki, Jacob Schachter, Gal Markel, Ronnie Shapira‐Frommer, Avraham J. Treves, Bruria Shalmon, Arnon Nagler, Daphna Levy and Avichai Shimoni and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Molecular Systems Biology.

In The Last Decade

Adva Kubi

13 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adva Kubi Israel 13 1.0k 747 278 233 86 13 1.2k
Marie-Andrée Forget United States 11 748 0.7× 500 0.7× 263 0.9× 150 0.6× 129 1.5× 12 947
Mary A. Black United States 11 1.1k 1.1× 681 0.9× 478 1.7× 295 1.3× 206 2.4× 16 1.3k
Junyun Lai Australia 13 819 0.8× 697 0.9× 336 1.2× 137 0.6× 182 2.1× 16 1.2k
Konstantin Dobrenkov United States 15 559 0.6× 363 0.5× 235 0.8× 190 0.8× 131 1.5× 28 829
Thomas E. Shelton United States 8 1.4k 1.4× 1.2k 1.6× 359 1.3× 282 1.2× 91 1.1× 8 1.6k
Katrin Töpfer Germany 11 655 0.6× 536 0.7× 246 0.9× 141 0.6× 105 1.2× 12 896
Parisa Malekzadeh United States 7 651 0.6× 377 0.5× 196 0.7× 101 0.4× 150 1.7× 14 795
Huiping Gao China 12 616 0.6× 392 0.5× 248 0.9× 90 0.4× 142 1.7× 22 889
Connie P.M. Duong United States 15 1.1k 1.1× 683 0.9× 379 1.4× 313 1.3× 259 3.0× 24 1.4k
Alba Rodríguez-García United States 13 637 0.6× 385 0.5× 283 1.0× 245 1.1× 181 2.1× 17 876

Countries citing papers authored by Adva Kubi

Since Specialization
Citations

This map shows the geographic impact of Adva Kubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adva Kubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adva Kubi more than expected).

Fields of papers citing papers by Adva Kubi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adva Kubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adva Kubi. The network helps show where Adva Kubi may publish in the future.

Co-authorship network of co-authors of Adva Kubi

This figure shows the co-authorship network connecting the top 25 collaborators of Adva Kubi. A scholar is included among the top collaborators of Adva Kubi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adva Kubi. Adva Kubi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Itzhaki, Orit, Adva Kubi, Elad Jacoby, et al.. (2022). Impact of cryopreservation on CAR T production and clinical response. Frontiers in Oncology. 12. 1024362–1024362. 23 indexed citations
2.
Itzhaki, Orit, Elad Jacoby, Arnon Nagler, et al.. (2020). Head-to-head comparison of in-house produced CD19 CAR-T cell in ALL and NHL patients. Journal for ImmunoTherapy of Cancer. 8(1). e000148–e000148. 37 indexed citations
3.
Besser, Michal J., Orit Itzhaki, Guy Ben‐Betzalel, et al.. (2020). Comprehensive single institute experience with melanoma TIL: Long term clinical results, toxicity profile, and prognostic factors of response. Molecular Carcinogenesis. 59(7). 736–744. 22 indexed citations
4.
Jacoby, Elad, Bella Bielorai, Abraham Avigdor, et al.. (2018). Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia. American Journal of Hematology. 93(12). 1485–1492. 85 indexed citations
5.
Ortenberg, Rona, Sivan Sapoznik, Douglas Zippel, et al.. (2015). Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy. Journal of Immunology Research. 2015. 1–8. 12 indexed citations
6.
Besser, Michal J., Ronnie Shapira‐Frommer, Orit Itzhaki, et al.. (2013). Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies. Clinical Cancer Research. 19(17). 4792–4800. 294 indexed citations
7.
Greenberg, Eyal, Michal J. Besser, Eytan Ben‐Ami, et al.. (2013). A comparative analysis of total serum miRNA profiles identifies novel signature that is highly indicative of metastatic melanoma: a pilot study. Biomarkers. 18(6). 502–508. 39 indexed citations
8.
Itzhaki, Orit, Eyal Greenberg, Bruria Shalmon, et al.. (2013). Nicotinamide Inhibits Vasculogenic Mimicry, an Alternative Vascularization Pathway Observed in Highly Aggressive Melanoma. PLoS ONE. 8(2). e57160–e57160. 47 indexed citations
9.
Itzhaki, Orit, Einat Hovav, Daphna Levy, et al.. (2011). Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy. Journal of Immunotherapy. 34(2). 212–220. 124 indexed citations
10.
Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2010). Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients. Clinical Cancer Research. 16(9). 2646–2655. 352 indexed citations
11.
Besser, Michal J., Ronnie Shapira‐Frommer, Avraham J. Treves, et al.. (2009). Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients. Journal of Immunotherapy. 32(4). 415–423. 97 indexed citations
12.
Markel, Gal, Rona Ortenberg, Rachel Seidman, et al.. (2009). Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunology Immunotherapy. 59(2). 215–230. 53 indexed citations
13.
Oved, Kfir, Eran Eden, Roy Noy, et al.. (2009). Predicting and controlling the reactivity of immune cell populations against cancer. Molecular Systems Biology. 5(1). 265–265. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026